LOCUS MICROBIAL SOLUTIONS
LOCUS MICROBIAL SOLUTIONS
Industry:
Biotechnology Pharmaceutical
Website Url:
http://www.locusmicrobes.com
Status:
Active
Technology used in webpage:
Amazon GoDaddy DNS AWS Global Accelerator GoDaddy Email
Similar Organizations
Agreen Biotech
Biotech company China
Raptamer Discovery Group
Biotechnology Company
Official Site Inspections
http://www.locusmicrobes.com
Unable to get host informations!!!
More informations about "Locus Microbial Solutions"
Locus Microbial Solutions - Crunchbase Company Profile & Funding
Locus Microbial Solutions is a biotech firm that creates solutions that outperform chemicals in a wide range of industries. It utilizes the power of microorganisms to create patented, biobased …See details»
Home - Locus Biosciences
We are trailblazers in the development of engineered bacteriophage products. Applying modern technologies, we are revolutionizing the treatment of bacterial infections and addressing unmet …See details»
Biologicals - Locus Ag
Subscribe to the Vital Input E-Newsletter. Don't miss out on the biological industry's most Vital Input! Subscribe to one of Locus AG's monthly e-newsletters and receive exclusive industry …See details»
Locus Biosciences - Wikipedia
Locus Biosciences is a clinical-stage pharmaceutical company, founded in 2015 and based in Research Triangle Park, North Carolina. Locus develops phage therapies based on CRISPR–Cas3 gene editing technology, as opposed to the more commonly used CRISPR-Cas9, delivered by engineered bacteriophages. The intended therapeutic targets are antibiotic-resistant bacterial infections. See details»
Locus Microbial Solutions - Overview, News & Similar ... - ZoomInfo
View Locus Microbial Solutions (www.locusmicrobes.com) location , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Locus Biosciences - Crunchbase Company Profile
Locus Biosciences may be growing as evidenced by the substantial financial support it has received for its clinical trials. The Biomedical Advanced Research and Development Authority (BARDA) has committed $24 million to support the …See details»
Locus AG | Agricultural Biologicals | Carbon …
Corn Our products consistently perform well in a variety of soils and make their impact at application. And, we have the 3rd party trial data to back it up! See More Row Crop Data 8.9 Yield …See details»
Locus Agricultural Solutions™ Develops Game-Changing Microbial ...
Jan 30, 2018 Locus AG is leveraging its core scientific capabilities from its parent organization, Locus Fermentation Solutions, LLC, an Ohio-based industrial bioscience company. For more …See details»
Locus Biosciences Gets CARB-X Funding for New UTI …
Nov 17, 2020 The non-profit organization, Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) , will provide up to $12.5 million of the $14.8 million needed to advance LPB-KP01. CARB-X supports …See details»
Locus Microbial Solutions Reviews | Read Client Reviews of Locus ...
Read reviews of Locus Microbial Solutions. Write and share your personal story. Your experience will help others make the right buying decision.See details»
Locus Biosciences Announces First Patient Treated in the …
Sep 13, 2022 Nearly 40 percent of patients with UTIs experience a recurrence within months of the first episode. Both the U.S. Centers for Disease Control and Prevention (CDC) and World …See details»
Locus Fermentation Solutions - Crunchbase Company Profile
Which industries do these Sub-Organization operate in? Show . Locus Performance Ingredients Subsidiary. Locus Bio-Energy Solutions, LLC Subsidiary. Locus Animal Nutrition Division. …See details»
BARDA backs Locus phage therapy for resistant E coli
Apr 19, 2025 BARDA has given $24 million to Locus Bio to support a mid-stage trial of bacteriophage therapy LBP-EC01 for resistant E coli infections.See details»
Programs - Locus Bioscience
LBP-PA01. LBP-PA01 is a precision medicine designed to target P. aeruginosa infections. It is an engineered bacteriophage product to precisely remove P. aeruginosa bacteria in patients with …See details»
Locus Biosciences acquires EpiBiome’s high-throughput discovery ...
Jul 17, 2018 Locus Biosciences Inc., an emerging biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products, announced today its acquisition of …See details»
Locus Biosciences Announces $23.9 Million in Funding from …
Jan 23, 2024 ELIMINATE trial is evaluating LBP-EC01 for treating urinary tract infections caused by drug-resistant E. coli Funding to support advancement into Part 2 of ELIMINATE trial …See details»
Locus Biosciences Receives $23.9 Million Boost for Bacteriophage ...
Jan 24, 2024 The Centers for Disease Control and Prevention and the World Health Organization have flagged antibiotic-resistant E. coli as a critical public health threat, …See details»
Human Microbes - Stool donors for FMT and research
The trillions of microbes that live in our guts impact & regulate every aspect of human health & development. This ecosystem of microbes -- comprising thousands of species of bacteria, …See details»
Farmers Are Switching to Microbial Inoculants And Then Some
Feb 5, 2025 Subscribe to the Vital Input E-Newsletter. Don't miss out on the biological industry's most Vital Input! Subscribe to one of Locus AG's monthly e-newsletters and receive exclusive …See details»
Emergence of transferable daptomycin resistance in Gram-positive ...
1 day ago The role of Staphylococcus aureus YycFG in gene regulation, biofilm organization and drug resistance. Antibiotics 10 , 1555 (2021). Article CAS PubMed PubMed Central Google …See details»